Episode 49 - Metformin for knee osteoarthritis

Inside Rheumavision Join Olivier in conversation with Cristiana Sieiro Santos and two semi-finalists from the second edition of Rheumavision 2026.

🎧 Want to get involved in EULAR Task Forces?In the latest #EMEUNET Podcast, Olivier, Luis & Renske break down:✔️ What a Task Force is✔️ Who’s involved✔️ How YOU can join

Join Renske Meijer & Milena Bond as they bring patients and healthcare professionals together to share perspectives that matter.Plus, Sophia Marantidou speaks with Dr Jean-Guillaume Letarouilly and Prof Claire Daien about the impact of lifestyle in rheumatic diseases.

Learn about the new EULAR Classification Criteria for Haemochromatosis Arthropathy — a key step forward for research and clinical practice.

Join Renske, Rudi, and Olivier for a special episode of the EMEUNET podcast—a quiz-style episode highlighting key rheumatology publications from 2025.Fun, interactive, and packed with take-home messagesyou won’t want to miss!

This week we dive into the Peer Review Programme — what it is, how it works, and why it matters for early-career rheumatologists.

Join Olivier & Guillermo as they speak with 3 winners of the EMEUNET Top 10 Abstracts Hear from:🔹 Lilla Gunkl-Tóth🔹 Kensuke Suga🔹 Carlo Tur

In this special EULAR Young PARE & EMEUNET Joint Podcast episode for World Arthritis Day 2025, themed “Achieve Your Dreams!”, we explore the hopes and aspirations of people living with rheumatic and musculoskeletal diseases (RMDs) and the young rheumatologists who support them. Hosted by Tanita-Christina Wilhelmer, featuring Marko Mladenovic and Marcos Séneca García Rodríguez from Young PARE and Pierre-Antoine Juge and Krystel Aouad from EMEUNET.

"Young and ambitious" – Renske chats with Dr. Luis Coronel, a passionate rheumatologist from Barcelona.Discover how he helped shape the EULAR ultrasound courses and what drives his journey!

Join Renske & Olivier as they talk with Prof. Flavia Ciccutini about repurposing metformin for patients with overweight or obesity.🔍 Challenges, insights & future research!